Dengue is an ongoing major public health concern in India, with 1,88,401 new cases being
reported in 2017 alone. New research from the International Centre for Genetic
Engineering and Biotechnology (ICGEB), New Delhi, describes a novel strategy
towards developing a vaccine for this disease that circumvents the risk of the
deadly dengue shock syndrome.